← Back to Search

High volume combined aerobic/resistance exercise for Diabetes (DEAL Trial)

Phase < 1
Waitlist Available
Led By Ron Sigal, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

The objective of this study is to determine the effects of supervised combined aerobic and resistance training, and the effects of stage-matched written materials delivered by mail or internet, alone or in combination, on glycemic control as reflected in A1C (glycated hemoglobin).

Eligible Conditions
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

6Treatment groups
Active Control
Placebo Group
Group I: High volume combined aerobic/resistance exerciseActive Control1 Intervention
Group II: Low volume combined aerobic/resistance exerciseActive Control1 Intervention
Low volume combined aerobic/resistance exercise
Group III: High volume combined A/R exercise, printouts, pedometersActive Control1 Intervention
High volume combined aerobic/resistance exercise, printouts, pedometers
Group IV: Low volume combined A/R exercise, printouts, pedometersActive Control1 Intervention
Low volume combined aerobic/resistance exercise, printouts, pedometers
Group V: Printed PA information, pedometers and step log groupActive Control1 Intervention
Printed physical activity information, pedometers and step log group
Group VI: ControlPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
808 Previous Clinical Trials
884,363 Total Patients Enrolled
3 Trials studying Diabetes
395 Patients Enrolled for Diabetes
Ron Sigal, MDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
131 Total Patients Enrolled
1 Trials studying Diabetes
131 Patients Enrolled for Diabetes
~2 spots leftby Nov 2025